Shijiazhuang Yiling Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Shijiazhuang Yiling Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥446.51 Million ≈ $65.34 Million USD) by net assets (CN¥10.70 Billion ≈ $1.57 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Cash flow conversion efficiency of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025. This chart illustrates how Shijiazhuang Yiling Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shijiazhuang Yiling Pharmaceutical Co Lt (002603) share price today for real-time trading data and today's change.
Shijiazhuang Yiling Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Shijiazhuang Yiling Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shijiazhuang Yiling Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shijiazhuang Yiling Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Shijiazhuang Yiling Pharmaceutical Co Lt (002603) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FSPG Hi-Tech Co Ltd
SHE:000973
|
0.011x |
|
Grand Canyon Education Inc
NASDAQ:LOPE
|
0.162x |
|
China Airlines Ltd
TW:2610
|
0.117x |
|
LS Corp
KO:006260
|
0.078x |
|
MAZDA MOTOR UNSP.ADR/2
F:MZA0
|
N/A |
|
Titan Cement International SA
BR:TITC
|
0.084x |
|
Centre Testing Intl Shenzhen
SHE:300012
|
0.052x |
|
Q2 Holdings
NYSE:QTWO
|
0.094x |
Annual Cash Flow Conversion Efficiency for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025. Review Shijiazhuang Yiling Pharmaceutical Co Lt free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥10.98 Billion ≈ $1.61 Billion |
CN¥1.78 Billion ≈ $259.96 Million |
0.162x | +170.10% |
| 2024-12-31 | CN¥10.20 Billion ≈ $1.49 Billion |
CN¥611.01 Million ≈ $89.41 Million |
0.060x | +340.66% |
| 2023-12-31 | CN¥11.44 Billion ≈ $1.67 Billion |
CN¥155.46 Million ≈ $22.75 Million |
0.014x | -95.74% |
| 2022-12-31 | CN¥10.93 Billion ≈ $1.60 Billion |
CN¥3.49 Billion ≈ $510.37 Million |
0.319x | +447.55% |
| 2021-12-31 | CN¥9.07 Billion ≈ $1.33 Billion |
CN¥528.69 Million ≈ $77.36 Million |
0.058x | -67.22% |
| 2020-12-31 | CN¥8.92 Billion ≈ $1.31 Billion |
CN¥1.59 Billion ≈ $232.11 Million |
0.178x | +1950.92% |
| 2019-12-31 | CN¥7.95 Billion ≈ $1.16 Billion |
CN¥68.93 Million ≈ $10.09 Million |
0.009x | -9.41% |
| 2018-12-31 | CN¥7.56 Billion ≈ $1.11 Billion |
CN¥72.37 Million ≈ $10.59 Million |
0.010x | -40.65% |
| 2017-12-31 | CN¥7.11 Billion ≈ $1.04 Billion |
CN¥114.65 Million ≈ $16.78 Million |
0.016x | -86.60% |
| 2016-12-31 | CN¥5.33 Billion ≈ $780.36 Million |
CN¥641.45 Million ≈ $93.86 Million |
0.120x | +340.29% |
| 2015-12-31 | CN¥4.83 Billion ≈ $706.40 Million |
CN¥131.88 Million ≈ $19.30 Million |
0.027x | +13.93% |
| 2014-12-31 | CN¥4.42 Billion ≈ $646.31 Million |
CN¥105.90 Million ≈ $15.50 Million |
0.024x | +84.57% |
| 2013-12-31 | CN¥4.26 Billion ≈ $623.13 Million |
CN¥55.32 Million ≈ $8.10 Million |
0.013x | -28.77% |
| 2012-12-31 | CN¥3.84 Billion ≈ $562.64 Million |
CN¥70.13 Million ≈ $10.26 Million |
0.018x | +116.53% |
| 2011-12-31 | CN¥3.70 Billion ≈ $541.67 Million |
CN¥-408.49 Million ≈ $-59.77 Million |
-0.110x | -140.17% |
| 2010-12-31 | CN¥1.09 Billion ≈ $159.65 Million |
CN¥299.72 Million ≈ $43.86 Million |
0.275x | -31.75% |
| 2009-12-31 | CN¥790.55 Million ≈ $115.68 Million |
CN¥318.21 Million ≈ $46.56 Million |
0.403x | -7.30% |
| 2008-12-31 | CN¥484.03 Million ≈ $70.83 Million |
CN¥210.18 Million ≈ $30.76 Million |
0.434x | -- |
About Shijiazhuang Yiling Pharmaceutical Co Ltd
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine in China and internationally. It offers dietary supplements, and healthy food and drinks; patent TCM products for respiratory health, cardiovascular disease, diabetes, mellitus, oncology, urologic disease, sleep-improving, and anti-aging; disinfection and pers… Read more